Biopharma Daily Stock Updates - 06/29/22
$XBI $74.80 | +1.0% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +1.6% Novavax COVID-19 Data...
top of page
${alertText}
Want unlimited access? Try Pro free for 7 days.
BPIQ Blog
- Jun 29, 2022
- 2 min
Free Biopharma Daily Stock Updates - 06/29/22
$XBI $74.80 | +1.0% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +1.6% Novavax COVID-19 Data...
- Jun 24, 2022
- 2 min
Biopharma Daily Stock Updates - 06/24/22
$XBI $77.06 | +1.09% Table of Contents: Pipeline Updates Business Updates Pipeline Updates #IKNA +29.4% (6/22) Ikena Oncology Receives...
- Jun 24, 2022
- 2 min
Free Biopharma Daily Stock Updates - 06/24/22
$XBI $77.06 | +1.09% Table of Contents: Pipeline Updates Business Updates Pipeline Updates #IKNA +29.4% (6/22) Ikena Oncology Receives...
- Jun 23, 2022
- 2 min
Biopharma Daily Stock Updates - 06/23/22
$XBI $76.23 | +6.18% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +14% Novavax Files...
- Jun 23, 2022
- 2 min
Free Biopharma Daily Stock Updates - 06/23/22
$XBI $76.23 | +6.18% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +14% Novavax Files...
- Jun 22, 2021
- 4 min
COVID-19 Therapeutic Stocks to Watch (June 2021)
Summary Over 40 Smid-Cap companies currently have active trials involving COVID therapeutics (this includes small molecules and...
- Sep 27
- 2 min
Big/Suspected Movers FAQ/User Guide
What is a Big-Mover™ event? Big-Mover™ events are upcoming high-impact biopharma catalyst events, usually clinical trial read-outs, that...
- Aug 28
- 1 min
Quarterly Big Mover Biotech Stocks To Watch
Our free Big-Mover Report: Listing of 10 of the biggest clinical readouts this quarter Use this info: To update your holdings before a...
- Aug 17
- 1 min
Q2 2023 Product Revenue Analyses
We have gone through the Q2 2023 financial reports to analysis each companies product revenue to see: Q2 '23 revenue Q2 '22 revenue Q2...
- Aug 15
- 3 min
BPIQ Q2 2023 Biotech Hedge Fund (13F) Analysis
Last updated 8/15/23 Summary: Hedge fund holdings can help you discover new investment ideas Get more stock idea and see the full list of...
- Aug 7
- 1 min
SYFOVRE (APLS) vs. IZERVAY (Astellas)
Tough month for APLS • 1st: safety issue surfaces for SYFOVRE ⇨ Retinal Vasculitis • Now: IZERVAY approved early ⇨ Good for AMD patients...
- Aug 7
- 1 min
BIIB & SAGE: Zuranolone
Big PDUFA from a big collaboration: BIIB & SAGE PDUFA - 8/5/23 - Zuranolone in MDD & PPD Collaboration since 2020… BIIB invested $1.5B in...
- Jul 31
- 1 min
Apellis Pharmaceuticals (APLS)
BIOPHARMA STOCK NEWS FLASH APLS provides SYFOVRE safety update Background: SYFOVRE approved by FDA • Feb 2023 • pegcetacoplan injection •...
- Jul 24
- 1 min
How to make $$$ investing in biopharma
Consistent with top 36 biopharma hedge funds • Each held 22-125 companies @ end Q1 ⇒ Stonepine (22 companies) ⇒ EcoR1 (58) ⇒ RA Capital...
- Jul 17
- 1 min
Scpharmaceuticals (SCPH)... Is Summer Stock Dip a Buying Opportunity?
Overview: • Under the radar companies • Huge upside • Difficult FDA approval behind them ⇒ Typical for drug device combo ⇒ 2 CRLs • But...
- Jul 17
- 1 min
PRTA & BMS Collaboration
PRTA tech validated by big BMS collaboration • BMS is part owner of PRTA BMS & PRTA collaboration highlights: 3/20/18 CELG & PRTA enter...
- Jul 14
- 2 min
Finally... Therapeutics that slow Alzheimer’s
But, which is the best? • Some anti-beta amyloids (ABs) made it ⇒ thru pos Ph3 ⇒ 1 full FDA approval But lots of ABs have died in...
- Jul 12
- 1 min
AAIC 2023 (Alzheimer's Association International Conference) - Annual Meeting
Summary: The Alzheimer's Association International Conference is taking place from July 16 - 20, 2023 Abstracts are embargoed until the...
- Jun 14
- 3 min
Smid-cap Biopharma M&A Activity Part 1 - Overall Activity
Summary: BPIQ monitors M&A of smid-cap biopharmas There has been an uptick in biopharma M&A since May 2022 Q2 2023 started off with a...
- May 18
- 4 min
Smid-cap Biopharma M&A activity Part 2 - "Fitting the Mold"
Summary: BPIQ monitors M&A of smid-cap biopharmas There has been an uptick in biopharma M&A since May 2022 Q2 2023 started off with a...
- May 16
- 3 min
BPIQ Q1 2023 Biotech Hedge Fund (13F) Analysis
Last updated 5/15/23 Summary: Hedge fund holdings can help you discover new investment ideas Get more stock idea and see the full list of...
- May 11
- 2 min
EHA 2023 (European Hematology Association) - Annual Meeting
Summary: The European Hematology Association Annual 2022 Meeting is taking place from June 8-11, 2023 EHA is an important event for...
- May 5
- 2 min
ASCO & EHA 2023 - Many Exciting Cancer Presentations Coming
First published 5/5/23 Summary: The American Society of Clinical Oncology Annual Meeting is taking place from June 2-6, 2023 The European...
- May 5
- 1 min
Biopharma Pulse: 5/1-5/5 Weekly Review
Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
- May 4
- 3 min
Smid-cap Biopharma M&A Activity Part 1 - Overall Activity
Summary: BPIQ monitors M&A of smid-cap biopharmas There has been an uptick in biopharma M&A since May 2022 Q2 2023 started off with a...
- May 3
- 3 min
Initial Public Offerings (IPOs) Historical Tracker - Six IPOs so far in 2023!
Originally posted 5/3/2023; last updated 6/29/23 Summary: IPOs occur when private companies go public (offer shares to the public for the...
- Apr 28
- 1 min
Biopharma Pulse: 4/24-4/28 Weekly Review
Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
- Apr 28
- 3 min
Big Movers in Q2... Which Indications are Most Common?
Summary There are four common indications seen in Q2 Big/Suspected Movers NASH/Liver disease, kidney disease, eye disease, and mental...
- Apr 28
- 1 min
Many Exciting Q1 2023 Reports Coming!
Summary: Q1 2023 quarterly financial reports have started! Many large cap biotechs have already reported, and we expect most of the...
- Apr 27
- 2 min
ASCO 2023 Titles Released Yesterday!
First published 5/5/23 Summary: The American Society of Clinical Oncology Annual Meeting is taking place from June 2-6, 2023 This annual...
- Apr 19
- 3 min
How did Companies Perform at AACR 2023?
First published 4/19/23 Summary: AACR wrapped up today with just a couple presentations and investor calls Which companies performed best...
- Apr 18
- 4 min
A Busy Last Week of April for PDUFAs!
Summary: As we are almost in the last week of April, many PDUFA decisions are still to come! Next week will be busy for PDUFAs, with 6...
- Apr 16
- 1 min
Biotech Stock Catalyst Watchlist - April 2023
AACR kicked off this weekend. 8 PDUFA events left in April. Other meeting/events happening as well. See the full table below. Connect...
- Apr 14
- 1 min
Biopharma Pulse: 4/17-4/21 Weekly Review
Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
- Apr 14
- 1 min
Biopharma Pulse - 4/10-4/14 Weekly Review
Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
- Apr 14
- 4 min
Hedge Fund Top Holdings - Q3 & Q4 '22
Summary: Every quarter we look at the 36 life science hedge funds to determine patterns and to see which tickers are most held by hedge...
- Apr 7
- 1 min
Biotech Stock Catalyst Watchlist - April 2023
The first week of April didn't have too many major events, although $IFRX did move +183% on Emergency Use Authorization. Looking forward,...
- Apr 7
- 1 min
Biopharma Pulse - 4/3 - 4/7 Weekly Review
Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
- Apr 6
- 4 min
Which April '23 PDUFAs are Seeing Run-Ups into Approval Decisions?
What Are We Looking At: There are six PDUFA dates in April 2023 for small to large cap biotech. However, a majority of these upcoming...
- Apr 3
- 2 min
How Did Q1 Hedge Fund Top 20 Returns Compare to Other Quarters?
Summary: We previously analyzed the 36 life science hedge funds to determine which smid-cap biopharmas were in the most Top 20s See our...
- Apr 2
- 1 min
Biotech Stock Catalyst Watchlist - April 2023
We've reached the end of Q1. April has a lot of events happening including 8 PDUFA's, the AACR cancer meeting, and some other company...
- Mar 31
- 1 min
Biopharma Pulse - 3/27 - 3/31 Weekly Review
Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
- Mar 29
- 2 min
AACR Starts April 14th!
Last updated 4/10/23 Summary: AACR is only a few weeks away - the conferences starts April 14th, also when abstract text is released What...
- Mar 28
- 2 min
AMGN v. Sanofi Ab Patent Case - What Biotech Investors Should Know
Amgen v. Sanofi Sup Ct. oral arguments took place yesterday in the ongoing PCSK9* antibody (Ab) patent case. See the attached transcript...
- Mar 24
- 1 min
Biotech Q1 '23 Final Catalyst Countdown
We've reached the final week of Q1. Anything that hasn't read out yet is coming this week! There's over 20 events still set to happen....
- Mar 24
- 1 min
Biopharma Pulse - 3/20 - 3/24 Weekly Review
Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
- Mar 22
- 2 min
ETNB Phase 2b Data Reported!!
Summary: Phase 2b ETNB ENLIVEN data was reported today (3/22/23) & trial met primary endpoints How does this data compare to previous...
- Mar 21
- 2 min
3 Mental Health Readouts Left as March Movers!
Summary: ITCI, NRXP & VTGN are left in our March Movers list, all are in the mental health category NRXP & VTGN are March Big Movers and...
- Mar 20
- 2 min
IONS & BIIB Tofersen AdComm on Wednesday!
Summary: The IONS and BIIB AdComm meeting for Tofersen is scheduled for this Wednesday, March 22! Briefing docs were released today...
- Mar 17
- 1 min
Biopharma Pulse - 3/13 - 3/17 Weekly Review
Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
- Mar 17
- 1 min
Biotech Q1 '23 Catalyst Countdown
We're coming down to the final weeks of Q1 2023. This past week XBI finished green up ~1%, although it still sits in the mid $70's. See...
- Mar 16
- 3 min
CDTX's Rezafungin PDUFA Coming Soon!
Summary: The CDTX PDUFA for Rezafungin to treat candidemia and invasive candidiasis is scheduled for March 22 Positive Phase 3 data from...
- Mar 15
- 2 min
Over 20 Smid-Cap Biopharmas Presenting at AACR 2023!
Summary: The American Association for Cancer Research (AACR) 2023 Annual Meeting will take place from April 14-19, 2023, abstracts...
- Mar 12
- 1 min
Biotech Catalyst Watchlist Q1 2023 Part 2
Each week we're posting a countdown of the remaining catalysts left in Q1! Last week was a rough week for biotech's with XBI finishing...
- Mar 10
- 1 min
Biopharma Pulse - 3/6 - 3/10 Weekly Review
Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
- Mar 7
- 2 min
ACAD's Trofinetide PDUFA Coming Sunday
Summary: The ACAD Trofinetide PDUFA is expected this Sunday March 12, 2023 Will we see an early decision before the weekend? See our full...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page